ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gastrointestinal Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: May 2025
|
Report Code: QYRE-Auto-3O396
Home | Market Reports | Health| Health Conditions
Global Gastrointestinal Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Gastrointestinal Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-3O396
Report
May 2025
Pages:136
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AstraZenec
Sanofi
Bayer
Pfizer Inc
Zeria（Tillotts）
Perrigo
Boehringer Ingelheim
Purdue Pharma
C.B. Fleet
Abbott
Jiangzhong
Xian Janssen
GlaxoSmithKline
GlaxoSmithKline PLC
TEVA

Gastrointestinal Market Size

In 2024, the global market size of Gastrointestinal was estimated to be worth US$ 37060 million and is forecast to reach approximately US$ 46370 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.

Gastrointestinal Market

Gastrointestinal Market

Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn"s disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.
Global Gastrointestinal key players include AstraZeneca, Sanofi, Bayer, Pfizer, GlaxoSmithKline, etc. Global top five manufacturers hold a share over 25%.
Europe is the largest market, with a share about 45%, followed by Asia, and North America, both have a share over 45 percent.
In terms of product, Prescription Gastrointestinal Drug is the largest segment, with a share over 80%. And in terms of application, the largest application is Chronic Gastritis, followed by Peptic Ulcer, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gastrointestinal, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastrointestinal.
The Gastrointestinal market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gastrointestinal market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastrointestinal companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation

Scope of Gastrointestinal Market Report

Report Metric Details
Report Name Gastrointestinal Market
CAGR 3.3%
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AstraZenec, Sanofi, Bayer, Pfizer, GlaxoSmithKline, Teva, Zeria（Tillotts）, Perrigo, Boehringer Ingelheim, Purdue Pharma, C.B. Fleet, Abbott, Jiangzhong, Xian-Janssen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
  • Chapter 2: Revenue of Gastrointestinal in global and regional level.
  • Chapter 3: Detailed analysis of Gastrointestinal company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gastrointestinal revenue, gross margin, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion

FAQ for this report

What is the market share of major companies in Gastrointestinal Market?

Ans: Global top five manufacturers hold a share over 25%.

What is the Gastrointestinal Market share by type?

Ans: In terms of product, Prescription Gastrointestinal Drug is the largest segment, with a share over 80%.

Who are the main players in the Gastrointestinal Market report?

Ans: The main players in the Gastrointestinal Market are AstraZenec, Sanofi, Bayer, Pfizer, GlaxoSmithKline, Teva, Zeria（Tillotts）, Perrigo, Boehringer Ingelheim, Purdue Pharma, C.B. Fleet, Abbott, Jiangzhong, Xian-Janssen

What are the Application segmentation covered in the Gastrointestinal Market report?

Ans: The Applications covered in the Gastrointestinal Market report are Chronic Gastritis, Functional Dyspepsia, Peptic Ulcer, Acute Gastroenteritis, Others

What are the Type segmentation covered in the Gastrointestinal Market report?

Ans: The Types covered in the Gastrointestinal Market report are Prescription Gastrointestinal Drug, OTC Gastrointestinal Drug

Recommended Reports

Gastrointestinal Drugs

GI Disease Therapeutics

GI Diagnostic Solutions

Market trends :

Topic Trends
Global the gastrointestinal market is experiencing steady growth driven by rising prevalence of chronic digestive disorders and increased demand for prescription drugs, with europe and asia-pacific leading regional expansion.
Type Prescription Gastrointestinal Drug - prescription gastrointestinal drugs dominate the market due to higher efficacy and increased physician recommendations for chronic conditions.
OTC Gastrointestinal Drug - otc gastrointestinal drugs are seeing moderate growth as consumers seek convenient solutions for mild digestive issues.
Application Chronic Gastritis - chronic gastritis remains the largest application segment, fueled by growing incidence and ongoing need for long-term management therapies.
Functional Dyspepsia - functional dyspepsia treatments are gaining traction as awareness and diagnosis rates increase globally.
Peptic Ulcer - peptic ulcer therapies continue to be a key focus due to persistent demand for effective symptom control and recurrence prevention.
Acute Gastroenteritis - acute gastroenteritis drug demand is stable, supported by periodic outbreaks and emphasis on rapid symptom relief.
Region North America - north america maintains robust demand for advanced gastrointestinal drugs, driven by high healthcare spending and innovation.
EMEA - europe leads the global gastrointestinal market, benefiting from strong healthcare infrastructure and high prevalence of digestive disorders.
APAC - asia-pacific is witnessing accelerated growth in gastrointestinal drug adoption due to rising disease awareness and expanding healthcare access.
LATAM - latin america shows gradual market expansion as healthcare investments and diagnosis rates improve.
1 Study Coverage
1.1 Gastrointestinal Product Introduction
1.2 Market by Type
1.2.1 Global Gastrointestinal Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Prescription Gastrointestinal Drug
1.2.3 OTC Gastrointestinal Drug
1.3 Market by Application
1.3.1 Global Gastrointestinal Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Chronic Gastritis
1.3.3 Functional Dyspepsia
1.3.4 Peptic Ulcer
1.3.5 Acute Gastroenteritis
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Gastrointestinal Market Size Estimates and Forecasts
2.2 Gastrointestinal Market Size by Region: 2024 Versus 2031
2.2.1 Global Gastrointestinal Revenue by Region: 2020-2025
2.2.2 Global Gastrointestinal Revenue Forecast by Region (2026-2031)
2.2.3 Global Gastrointestinal Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Gastrointestinal Revenue by Type (2020-2031)
3.1.2 Global Gastrointestinal Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Gastrointestinal Revenue by Application (2020-2031)
3.2.2 Global Gastrointestinal Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Prescription Gastrointestinal Drug of Gastrointestinal Revenue Market Share by Application
3.3.2 OTC Gastrointestinal Drug of Gastrointestinal Revenue Market Share by Application
4 Global Gastrointestinal by Company
4.1 Global Gastrointestinal Revenue by Company (2020-2025)
4.2 Global Gastrointestinal Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Gastrointestinal Companies around the World: Ranking by Revenue
4.3.2 Global Gastrointestinal Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Gastrointestinal Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Gastrointestinal Companies Headquarters & Product Type
4.4.1 Global Gastrointestinal Companies Headquarters
4.4.2 Date of International Companies Enter into Gastrointestinal Market
4.4.3 Global Gastrointestinal Companies Product & Service
4.4.4 Prescription Gastrointestinal Drug Revenue Market Share of Gastrointestinal by Company
4.4.5 OTC Gastrointestinal Drug Revenue Market Share of Gastrointestinal by Company
4.5 Global Gastrointestinal Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 AstraZenec
5.1.1 AstraZenec Corporation Information
5.1.2 AstraZenec Description, Business Overview
5.1.3 AstraZenec Gastrointestinal Products Offered
5.1.4 AstraZenec Gastrointestinal Revenue and Gross Margin (2020-2025)
5.1.5 AstraZenec Gastrointestinal Revenue by Product in 2024
5.1.6 AstraZenec Gastrointestinal Revenue by Application in 2024
5.1.7 AstraZenec Gastrointestinal Revenue by Geographic Area in 2024
5.1.8 AstraZenec Recent Developments
5.2 Sanofi
5.2.1 Sanofi Corporation Information
5.2.2 Sanofi Description, Business Overview
5.2.3 Sanofi Gastrointestinal Products Offered
5.2.4 Sanofi Gastrointestinal Revenue and Gross Margin (2020-2025)
5.2.5 Sanofi Gastrointestinal Revenue by Product in 2024
5.2.6 Sanofi Gastrointestinal Revenue by Application in 2024
5.2.7 Sanofi Gastrointestinal Revenue by Geographic Area in 2024
5.2.8 Sanofi Recent Developments
5.3 Bayer
5.3.1 Bayer Corporation Information
5.3.2 Bayer Description, Business Overview
5.3.3 Bayer Gastrointestinal Products Offered
5.3.4 Bayer Gastrointestinal Revenue and Gross Margin (2020-2025)
5.3.5 Bayer Gastrointestinal Revenue by Product in 2024
5.3.6 Bayer Gastrointestinal Revenue by Application in 2024
5.3.7 Bayer Gastrointestinal Revenue by Geographic Area in 2024
5.3.8 Bayer Recent Developments
5.4 Pfizer
5.4.1 Pfizer Corporation Information
5.4.2 Pfizer Description, Business Overview
5.4.3 Pfizer Gastrointestinal Products Offered
5.4.4 Pfizer Gastrointestinal Revenue and Gross Margin (2020-2025)
5.4.5 Pfizer Gastrointestinal Revenue by Product in 2024
5.4.6 Pfizer Gastrointestinal Revenue by Application in 2024
5.4.7 Pfizer Gastrointestinal Revenue by Geographic Area in 2024
5.4.8 Pfizer Recent Developments
5.5 GlaxoSmithKline
5.5.1 GlaxoSmithKline Corporation Information
5.5.2 GlaxoSmithKline Description, Business Overview
5.5.3 GlaxoSmithKline Gastrointestinal Products Offered
5.5.4 GlaxoSmithKline Gastrointestinal Revenue and Gross Margin (2020-2025)
5.5.5 GlaxoSmithKline Gastrointestinal Revenue by Product in 2024
5.5.6 GlaxoSmithKline Gastrointestinal Revenue by Application in 2024
5.5.7 GlaxoSmithKline Gastrointestinal Revenue by Geographic Area in 2024
5.5.8 GlaxoSmithKline Recent Developments
5.6 Teva
5.6.1 Teva Corporation Information
5.6.2 Teva Description, Business Overview
5.6.3 Teva Gastrointestinal Products Offered
5.6.4 Teva Gastrointestinal Revenue and Gross Margin (2020-2025)
5.6.5 Teva Gastrointestinal Revenue by Product in 2024
5.6.6 Teva Gastrointestinal Revenue by Application in 2024
5.6.7 Teva Gastrointestinal Revenue by Geographic Area in 2024
5.6.8 Teva Recent Developments
5.7 Zeria（Tillotts）
5.7.1 Zeria（Tillotts） Corporation Information
5.7.2 Zeria（Tillotts） Description, Business Overview
5.7.3 Zeria（Tillotts） Gastrointestinal Products Offered
5.7.4 Zeria（Tillotts） Gastrointestinal Revenue and Gross Margin (2020-2025)
5.7.5 Zeria（Tillotts） Gastrointestinal Revenue by Product in 2024
5.7.6 Zeria（Tillotts） Gastrointestinal Revenue by Application in 2024
5.7.7 Zeria（Tillotts） Gastrointestinal Revenue by Geographic Area in 2024
5.7.8 Zeria（Tillotts） Recent Developments
5.8 Perrigo
5.8.1 Perrigo Corporation Information
5.8.2 Perrigo Description, Business Overview
5.8.3 Perrigo Gastrointestinal Products Offered
5.8.4 Perrigo Gastrointestinal Revenue and Gross Margin (2020-2025)
5.8.5 Perrigo Gastrointestinal Revenue by Product in 2024
5.8.6 Perrigo Gastrointestinal Revenue by Application in 2024
5.8.7 Perrigo Gastrointestinal Revenue by Geographic Area in 2024
5.8.8 Perrigo Recent Developments
5.9 Boehringer Ingelheim
5.9.1 Boehringer Ingelheim Corporation Information
5.9.2 Boehringer Ingelheim Description, Business Overview
5.9.3 Boehringer Ingelheim Gastrointestinal Products Offered
5.9.4 Boehringer Ingelheim Gastrointestinal Revenue and Gross Margin (2020-2025)
5.9.5 Boehringer Ingelheim Gastrointestinal Revenue by Product in 2024
5.9.6 Boehringer Ingelheim Gastrointestinal Revenue by Application in 2024
5.9.7 Boehringer Ingelheim Gastrointestinal Revenue by Geographic Area in 2024
5.9.8 Boehringer Ingelheim Recent Developments
5.10 Purdue Pharma
5.10.1 Purdue Pharma Corporation Information
5.10.2 Purdue Pharma Description, Business Overview
5.10.3 Purdue Pharma Gastrointestinal Products Offered
5.10.4 Purdue Pharma Gastrointestinal Revenue and Gross Margin (2020-2025)
5.10.5 Purdue Pharma Gastrointestinal Revenue by Product in 2024
5.10.6 Purdue Pharma Gastrointestinal Revenue by Application in 2024
5.10.7 Purdue Pharma Gastrointestinal Revenue by Geographic Area in 2024
5.10.8 Purdue Pharma Recent Developments
5.11 C.B. Fleet
5.11.1 C.B. Fleet Corporation Information
5.11.2 C.B. Fleet Description, Business Overview
5.11.3 C.B. Fleet Gastrointestinal Products Offered
5.11.4 C.B. Fleet Gastrointestinal Revenue and Gross Margin (2020-2025)
5.11.5 C.B. Fleet Gastrointestinal Revenue by Product in 2024
5.11.6 C.B. Fleet Gastrointestinal Revenue by Application in 2024
5.11.7 C.B. Fleet Gastrointestinal Revenue by Geographic Area in 2024
5.11.8 C.B. Fleet Recent Developments
5.12 Abbott
5.12.1 Abbott Corporation Information
5.12.2 Abbott Description, Business Overview
5.12.3 Abbott Gastrointestinal Products Offered
5.12.4 Abbott Gastrointestinal Revenue and Gross Margin (2020-2025)
5.12.5 Abbott Gastrointestinal Revenue by Product in 2024
5.12.6 Abbott Gastrointestinal Revenue by Application in 2024
5.12.7 Abbott Gastrointestinal Revenue by Geographic Area in 2024
5.12.8 Abbott Recent Developments
5.13 Jiangzhong
5.13.1 Jiangzhong Corporation Information
5.13.2 Jiangzhong Description, Business Overview
5.13.3 Jiangzhong Gastrointestinal Products Offered
5.13.4 Jiangzhong Gastrointestinal Revenue and Gross Margin (2020-2025)
5.13.5 Jiangzhong Gastrointestinal Revenue by Product in 2024
5.13.6 Jiangzhong Gastrointestinal Revenue by Application in 2024
5.13.7 Jiangzhong Gastrointestinal Revenue by Geographic Area in 2024
5.13.8 Jiangzhong Recent Developments
5.14 Xian-Janssen
5.14.1 Xian-Janssen Corporation Information
5.14.2 Xian-Janssen Description, Business Overview
5.14.3 Xian-Janssen Gastrointestinal Products Offered
5.14.4 Xian-Janssen Gastrointestinal Revenue and Gross Margin (2020-2025)
5.14.5 Xian-Janssen Gastrointestinal Revenue by Product in 2024
5.14.6 Xian-Janssen Gastrointestinal Revenue by Application in 2024
5.14.7 Xian-Janssen Gastrointestinal Revenue by Geographic Area in 2024
5.14.8 Xian-Janssen Recent Developments
6 North America
6.1 North America Gastrointestinal Market Size YoY Growth 2020-2031
6.2 North America Gastrointestinal Market Facts & Figures by Country (2020-2031)
6.3 North America Gastrointestinal Revenue by Type (2020-2025)
6.4 North America Gastrointestinal Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Gastrointestinal Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Gastrointestinal Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Gastrointestinal Revenue by Type (2020-2025)
7.4 Asia-Pacific Gastrointestinal Revenue by Application (2020-2025)
8 Europe
8.1 Europe Gastrointestinal Market Size YoY Growth 2020-2031
8.2 Europe Gastrointestinal Market Facts & Figures by Country (2020-2031)
8.3 Europe Gastrointestinal Revenue by Type (2020-2025)
8.4 Europe Gastrointestinal Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Gastrointestinal Market Size YoY Growth 2020-2031
9.2 Latin America Gastrointestinal Market Facts & Figures by Country (2020-2031)
9.3 Latin America Gastrointestinal Revenue by Type (2020-2025)
9.4 Latin America Gastrointestinal Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Gastrointestinal Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Gastrointestinal Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Gastrointestinal Revenue by Type (2020-2025)
10.4 Middle East and Africa Gastrointestinal Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Gastrointestinal Supply Chain Analysis
11.2 Gastrointestinal Key Raw Materials and Upstream Suppliers
11.3 Gastrointestinal Clients Analysis
11.4 Gastrointestinal Sales Channel and Sales Model Analysis
11.4.1 Gastrointestinal Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Gastrointestinal Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Gastrointestinal Distributors
12 Gastrointestinal Market Dynamics
12.1 Gastrointestinal Industry Trends
12.2 Gastrointestinal Market Drivers
12.3 Gastrointestinal Market Challenges
12.4 Gastrointestinal Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
AstraZenec
Sanofi
Bayer
Pfizer Inc
Zeria（Tillotts）
Perrigo
Boehringer Ingelheim
Purdue Pharma
C.B. Fleet
Abbott
Jiangzhong
Xian Janssen
GlaxoSmithKline
GlaxoSmithKline PLC
TEVA
List of Tables
 Table 1. Global Gastrointestinal Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Gastrointestinal Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Gastrointestinal Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Gastrointestinal Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Gastrointestinal Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 6. Global Gastrointestinal Revenue by Type (2020-2025) & (US$ Million)
 Table 7. Global Gastrointestinal Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 8. Global Gastrointestinal Revenue by Application (2020-2025) & (US$ Million)
 Table 9. Global Gastrointestinal Revenue Forecast by Application (2026-2031) & (US$ Million)
 Table 10. Gastrointestinal Revenue by Company (2020-2025) & (US$ Million)
 Table 11. Gastrointestinal Revenue Share by Company (2020-2025)
 Table 12. Ranking of Global Top Gastrointestinal Players by Revenue (US$ Million) in 2024
 Table 13. Global Gastrointestinal Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 14. Global Gastrointestinal by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal as of 2024)
 Table 15. Global Gastrointestinal Companies Headquarters
 Table 16. Date of International Companies Enter into Gastrointestinal Market
 Table 17. Global Gastrointestinal Companies Product & Service
 Table 18. Global Gastrointestinal Mergers & Acquisitions, Expansion Plans
 Table 19. AstraZenec Corporation Information
 Table 20. AstraZenec Description and Business Overview
 Table 21. AstraZenec Gastrointestinal Product
 Table 22. AstraZenec Gastrointestinal Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 23. AstraZenec Revenue Proportion of Gastrointestinal by Product in 2024
 Table 24. AstraZenec Revenue Proportion of Gastrointestinal by Application in 2024
 Table 25. AstraZenec Revenue Proportion of Gastrointestinal by Geographic Area in 2024
 Table 26. AstraZenec Recent Developments
 Table 27. Sanofi Corporation Information
 Table 28. Sanofi Description and Business Overview
 Table 29. Sanofi Gastrointestinal Product
 Table 30. Sanofi Gastrointestinal Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 31. Sanofi Revenue Proportion of Gastrointestinal by Product in 2024
 Table 32. Sanofi Revenue Proportion of Gastrointestinal by Application in 2024
 Table 33. Sanofi Revenue Proportion of Gastrointestinal by Geographic Area in 2024
 Table 34. Sanofi Recent Developments
 Table 35. Bayer Corporation Information
 Table 36. Bayer Description and Business Overview
 Table 37. Bayer Gastrointestinal Product
 Table 38. Bayer Gastrointestinal Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 39. Bayer Revenue Proportion of Gastrointestinal by Product in 2024
 Table 40. Bayer Revenue Proportion of Gastrointestinal by Application in 2024
 Table 41. Bayer Revenue Proportion of Gastrointestinal by Geographic Area in 2024
 Table 42. Bayer Recent Developments
 Table 43. Pfizer Corporation Information
 Table 44. Pfizer Description and Business Overview
 Table 45. Pfizer Gastrointestinal Product
 Table 46. Pfizer Gastrointestinal Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Pfizer Revenue Proportion of Gastrointestinal by Product in 2024
 Table 48. Pfizer Revenue Proportion of Gastrointestinal by Application in 2024
 Table 49. Pfizer Revenue Proportion of Gastrointestinal by Geographic Area in 2024
 Table 50. Pfizer Recent Developments
 Table 51. GlaxoSmithKline Corporation Information
 Table 52. GlaxoSmithKline Description and Business Overview
 Table 53. GlaxoSmithKline Gastrointestinal Product
 Table 54. GlaxoSmithKline Gastrointestinal Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 55. GlaxoSmithKline Revenue Proportion of Gastrointestinal by Product in 2024
 Table 56. GlaxoSmithKline Revenue Proportion of Gastrointestinal by Application in 2024
 Table 57. GlaxoSmithKline Revenue Proportion of Gastrointestinal by Geographic Area in 2024
 Table 58. GlaxoSmithKline Recent Developments
 Table 59. Teva Corporation Information
 Table 60. Teva Description and Business Overview
 Table 61. Teva Gastrointestinal Product
 Table 62. Teva Gastrointestinal Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 63. Teva Revenue Proportion of Gastrointestinal by Product in 2024
 Table 64. Teva Revenue Proportion of Gastrointestinal by Application in 2024
 Table 65. Teva Revenue Proportion of Gastrointestinal by Geographic Area in 2024
 Table 66. Teva Recent Developments
 Table 67. Zeria（Tillotts） Corporation Information
 Table 68. Zeria（Tillotts） Description and Business Overview
 Table 69. Zeria（Tillotts） Gastrointestinal Product
 Table 70. Zeria（Tillotts） Gastrointestinal Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 71. Zeria（Tillotts） Revenue Proportion of Gastrointestinal by Product in 2024
 Table 72. Zeria（Tillotts） Revenue Proportion of Gastrointestinal by Application in 2024
 Table 73. Zeria（Tillotts） Revenue Proportion of Gastrointestinal by Geographic Area in 2024
 Table 74. Zeria（Tillotts） Recent Developments
 Table 75. Perrigo Corporation Information
 Table 76. Perrigo Description and Business Overview
 Table 77. Perrigo Gastrointestinal Product
 Table 78. Perrigo Gastrointestinal Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 79. Perrigo Revenue Proportion of Gastrointestinal by Product in 2024
 Table 80. Perrigo Revenue Proportion of Gastrointestinal by Application in 2024
 Table 81. Perrigo Revenue Proportion of Gastrointestinal by Geographic Area in 2024
 Table 82. Perrigo Recent Developments
 Table 83. Boehringer Ingelheim Corporation Information
 Table 84. Boehringer Ingelheim Description and Business Overview
 Table 85. Boehringer Ingelheim Gastrointestinal Product
 Table 86. Boehringer Ingelheim Gastrointestinal Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 87. Boehringer Ingelheim Revenue Proportion of Gastrointestinal by Product in 2024
 Table 88. Boehringer Ingelheim Revenue Proportion of Gastrointestinal by Application in 2024
 Table 89. Boehringer Ingelheim Revenue Proportion of Gastrointestinal by Geographic Area in 2024
 Table 90. Boehringer Ingelheim Recent Developments
 Table 91. Purdue Pharma Corporation Information
 Table 92. Purdue Pharma Description and Business Overview
 Table 93. Purdue Pharma Gastrointestinal Product
 Table 94. Purdue Pharma Gastrointestinal Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 95. Purdue Pharma Revenue Proportion of Gastrointestinal by Product in 2024
 Table 96. Purdue Pharma Revenue Proportion of Gastrointestinal by Application in 2024
 Table 97. Purdue Pharma Revenue Proportion of Gastrointestinal by Geographic Area in 2024
 Table 98. Purdue Pharma Recent Developments
 Table 99. C.B. Fleet Corporation Information
 Table 100. C.B. Fleet Description and Business Overview
 Table 101. C.B. Fleet Gastrointestinal Product
 Table 102. C.B. Fleet Gastrointestinal Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. C.B. Fleet Revenue Proportion of Gastrointestinal by Product in 2024
 Table 104. C.B. Fleet Revenue Proportion of Gastrointestinal by Application in 2024
 Table 105. C.B. Fleet Revenue Proportion of Gastrointestinal by Geographic Area in 2024
 Table 106. C.B. Fleet Recent Developments
 Table 107. Abbott Corporation Information
 Table 108. Abbott Description and Business Overview
 Table 109. Abbott Gastrointestinal Product
 Table 110. Abbott Gastrointestinal Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 111. Abbott Revenue Proportion of Gastrointestinal by Product in 2024
 Table 112. Abbott Revenue Proportion of Gastrointestinal by Application in 2024
 Table 113. Abbott Revenue Proportion of Gastrointestinal by Geographic Area in 2024
 Table 114. Abbott Recent Developments
 Table 115. Jiangzhong Corporation Information
 Table 116. Jiangzhong Description and Business Overview
 Table 117. Jiangzhong Gastrointestinal Product
 Table 118. Jiangzhong Gastrointestinal Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 119. Jiangzhong Revenue Proportion of Gastrointestinal by Product in 2024
 Table 120. Jiangzhong Revenue Proportion of Gastrointestinal by Application in 2024
 Table 121. Jiangzhong Revenue Proportion of Gastrointestinal by Geographic Area in 2024
 Table 122. Jiangzhong Recent Developments
 Table 123. Xian-Janssen Corporation Information
 Table 124. Xian-Janssen Description and Business Overview
 Table 125. Xian-Janssen Gastrointestinal Product
 Table 126. Xian-Janssen Gastrointestinal Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 127. Xian-Janssen Revenue Proportion of Gastrointestinal by Product in 2024
 Table 128. Xian-Janssen Revenue Proportion of Gastrointestinal by Application in 2024
 Table 129. Xian-Janssen Revenue Proportion of Gastrointestinal by Geographic Area in 2024
 Table 130. Xian-Janssen Recent Developments
 Table 131. North America Gastrointestinal Revenue by Country (2020-2025) & (US$ Million)
 Table 132. North America Gastrointestinal Revenue by Country (2026-2031) & (US$ Million)
 Table 133. North America Gastrointestinal Revenue by Type (2020-2025) & (US$ Million)
 Table 134. North America Gastrointestinal Revenue by Application (2020-2025) & (US$ Million)
 Table 135. Asia-Pacific Gastrointestinal Revenue by Region (2020-2025) & (US$ Million)
 Table 136. Asia-Pacific Gastrointestinal Revenue by Region (2026-2031) & (US$ Million)
 Table 137. Asia-Pacific Gastrointestinal Revenue by Type (2020-2025) & (US$ Million)
 Table 138. Asia-Pacific Gastrointestinal Revenue by Application (2020-2025) & (US$ Million)
 Table 139. Europe Gastrointestinal Revenue by Country (2020-2025) & (US$ Million)
 Table 140. Europe Gastrointestinal Revenue by Country (2026-2031) & (US$ Million)
 Table 141. Europe Gastrointestinal Revenue by Type (2020-2025) & (US$ Million)
 Table 142. Europe Gastrointestinal Revenue by Application (2020-2025) & (US$ Million)
 Table 143. Latin America Gastrointestinal Revenue by Country (2020-2025) & (US$ Million)
 Table 144. Latin America Gastrointestinal Revenue by Country (2026-2031) & (US$ Million)
 Table 145. Latin America Gastrointestinal Revenue by Type (2020-2025) & (US$ Million)
 Table 146. Latin America Gastrointestinal Revenue by Application (2020-2025) & (US$ Million)
 Table 147. Middle East and Africa Gastrointestinal Revenue by Country (2020-2025) & (US$ Million)
 Table 148. Middle East and Africa Gastrointestinal Revenue by Country (2026-2031) & (US$ Million)
 Table 149. Middle East and Africa Gastrointestinal Revenue by Type (2020-2025) & (US$ Million)
 Table 150. Middle East and Africa Gastrointestinal Revenue by Application (2020-2025) & (US$ Million)
 Table 151. Gastrointestinal Key Raw Materials, Industry Status and Trend
 Table 152. Gastrointestinal Key Raw Materials and Upstream Suppliers
 Table 153. Gastrointestinal Clients Status and Trend
 Table 154. Gastrointestinal Typical Clients
 Table 155. Gastrointestinal Distributors
 Table 156. Gastrointestinal Market Trends
 Table 157. Gastrointestinal Market Drivers
 Table 158. Gastrointestinal Market Challenges
 Table 159. Gastrointestinal Market Restraints
 Table 160. Research Programs/Design for This Report
 Table 161. Key Data Information from Secondary Sources
 Table 162. Key Data Information from Primary Sources


List of Figures
 Figure 1. Gastrointestinal Product Picture
 Figure 2. Global Gastrointestinal Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Gastrointestinal Revenue Market Share by Type in 2024 & 2031
 Figure 4. Prescription Gastrointestinal Drug Product Picture
 Figure 5. OTC Gastrointestinal Drug Product Picture
 Figure 6. Global Gastrointestinal Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 7. Global Gastrointestinal Revenue Market Share by Application in 2024 & 2031
 Figure 8. Chronic Gastritis
 Figure 9. Functional Dyspepsia
 Figure 10. Peptic Ulcer
 Figure 11. Acute Gastroenteritis
 Figure 12. Others
 Figure 13. Gastrointestinal Report Years Considered
 Figure 14. Global Gastrointestinal Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Gastrointestinal Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Gastrointestinal Market Size Market Share by Region: 2024 Versus 2031
 Figure 17. Global Gastrointestinal Revenue Market Share by Region (2020-2031)
 Figure 18. Global Gastrointestinal Revenue Market Share Forecast by Type (2020-2031)
 Figure 19. Global Gastrointestinal Revenue Market Share Forecast by Application (2020-2031)
 Figure 20. Prescription Gastrointestinal Drug of Gastrointestinal Revenue Market Share by Application, 2024 VS 2031
 Figure 21. OTC Gastrointestinal Drug of Gastrointestinal Revenue Market Share by Application, 2024 VS 2031
 Figure 22. Gastrointestinal Revenue Share by Company (2024)
 Figure 23. Gastrointestinal Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Prescription Gastrointestinal Drug Revenue Proportion by Company in 2024
 Figure 25. OTC Gastrointestinal Drug Revenue Proportion by Company in 2024
 Figure 26. North America Gastrointestinal Revenue 2020-2031 (US$ Million)
 Figure 27. North America Gastrointestinal Revenue Market Share by Type (2020-2025)
 Figure 28. North America Gastrointestinal Revenue Market Share by Application (2020-2025)
 Figure 29. Asia-Pacific Gastrointestinal Revenue 2020-2031 (US$ Million)
 Figure 30. Asia-Pacific Gastrointestinal Revenue Market Share by Region (2020-2031)
 Figure 31. Asia-Pacific Gastrointestinal Revenue Market Share by Type (2020-2025)
 Figure 32. Asia-Pacific Gastrointestinal Revenue Market Share by Application (2020-2025)
 Figure 33. Europe Gastrointestinal Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 34. Europe Gastrointestinal Revenue Market Share by Country (2020-2031)
 Figure 35. Europe Gastrointestinal Revenue Market Share by Type (2020-2025)
 Figure 36. Europe Gastrointestinal Revenue Market Share by Application (2020-2025)
 Figure 37. Latin America Gastrointestinal Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 38. Latin America Gastrointestinal Revenue Market Share by Country (2020-2031)
 Figure 39. Latin America Gastrointestinal Revenue Market Share by Type (2020-2025)
 Figure 40. Latin America Gastrointestinal Revenue Market Share by Application (2020-2025)
 Figure 41. Middle East and Africa Gastrointestinal Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 42. Middle East and Africa Gastrointestinal Revenue Market Share by Country (2020-2031)
 Figure 43. Middle East and Africa Gastrointestinal Revenue Market Share by Type (2020-2025)
 Figure 44. Middle East and Africa Gastrointestinal Revenue Market Share by Application (2020-2025)
 Figure 45. Gastrointestinal Supply Chain (Upstream and Downstream Market)
 Figure 46. Global Production Market Share of Gastrointestinal Raw Materials by Region in 2024
 Figure 47. Gastrointestinal Distribution Channels
 Figure 48. Global Gastrointestinal Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 49. Global Gastrointestinal Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 50. Bottom-up and Top-down Approaches for This Report
 Figure 51. Data Triangulation
 Figure 52. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Gastrointestinal Drugs Market Research Report 2025
Global Gastrointestinal Therapeutics Market Research Report 2024
Gastrointestinal Disorder Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Peptide Based Gastrointestinal Disorders Therapeutics Market Research Report 2024
Global Prescription Gastrointestinal Drugs Market Research Report 2024
Irritable Bowel Syndrome Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Digestive Drugs Market Insights Forecast to 2030
Gastrointestinal Therapeutics and Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global OTC Gastrointestinal Products Market Research Report 2024
Global Gastrointestinal OTC Drugs Market Research Report 2024
Global Irritable Bowel Syndrome IBS Market Insights Forecast to 2030
Irritable Bowel Syndrome Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Inflammatory Bowel Disease Relief Market Insights Forecast to 2030
Global Digestive Remedies Market Research Report 2024
Global Crohn s Disease Diagnostic and Therapeutic Market Insights Forecast to 2030
Global OTC Digestives and Intestinal Remedies Market Research Report 2024
Irritable Bowel Syndrome IBS Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gastrointestinal Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Inflammatory Bowel Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gastroenterology Devices Market Insights Forecast to 2030

RELATED REPORTS

Global Insulin Coolers Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19Z7671
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Ossicular Prostheses Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10V14317
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Defibrillator Accessories Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10O5919
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Septicemia Diagnostic Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4I19963
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions